The American chipmaker is recording clear declines in pre-market trading during Monday’s session. The drop is hovering around 4%.
These declines were driven mainly by Elon Musk’s comments about TSMC cooperating with the “Terra Fab” joint venture. By way of reminder, the “Terra Fab” initiative is a project for a huge, vertically integrated processor manufacturing process that is meant to deliver an almost unrivaled price and volume while maintaining advanced products.
Intel was expected to be part of the Terra Fab initiative, with the company acting as a supplier of manufacturing process technology for chip production. Specifically, this refers to the “Intel 14A” process, i.e., manufacturing chips in 1.4 nm technology.
A seat at the table
Elon Musk commented on his platform “X” in response to analyses by a columnist on the “Substack” platform named “Culpium.” “Culpium” pointed to sources inside TSMC suggesting that possibilities for cooperation between TSMC and representatives of Elon Musk’s companies were being explored. The CEO of Tesla and SpaceX reportedly confirmed these speculations.
A correction from Elon Musk quickly followed. He indicated that if TSMC cooperation were to develop in the context of Terra Fab, it would be supplementary in nature. However, the degree of this “supplementation” was not specified, placing Intel in an uncomfortable position.
The return of the king, or the return of problems?
Intel itself can boast an impressive rally in its shares, currently showing about a 220% increase since the beginning of the year. Given that the company is still generating significant net losses, it must achieve a great deal of its stated goals to justify a market capitalization of around USD 630 billion.
Intel price chart (D1)
Source: xStation5
Intel’s participation in Terra Fab is not only a matter of financial success or failure. Successful integration of the Intel 14A process within Elon Musk’s project would be a clear message to the market that the company’s solutions are not only returning to the technological vanguard in terms of declarations, but also operationally. It would be a starting point for regaining some trust, prestige, and most importantly, market share. The need to “share” success with TSMC calls the validity of this scenario into question.
Sentiment versus facts
The scale of any potential disappointment is difficult to estimate at present. Intel has not published any forecasts or expectations related to its participation in Terra Fab.
Even the target settlement or revenue-sharing mechanisms between project participants are not publicly known. At the moment, the only point of reference is an answer from the Q1 2026 earnings call, in which Intel representatives, asked whether revenue from Terra Fab would be counted as “foundry” revenue, responded that the relationship is “very broad” and details would be provided later. This allows observers to infer deep integration of Intel into the project and potentially a meaningful share in profits, but for now these remain only speculations.
Equally important, if not more so, the assumption that Intel would remain the sole supplier of technology and solutions for a project as enormous as Terra Fab was optimistic, if not naive. TSMC, which currently accounts for about 80% of contract “AI” chip production, is estimated, based on dispersed customer data, to produce around 5–10 million processors of this type per year. The Terra Fab initiative targets annual production of around 100–200 million chips. Even if Elon Musk’s project reached only 10% of the target volume, that would mean at least matching TSMC’s production volume, which would imply almost doubling global production.
Daily Summary: A Shallow Rebound Ahead of Earnings Season
Lumentum: Demand for AI infrastructure exceeds capacity
US OPEN: Trump de-escalates, OpenAI supports Wall Street sentiment
Morning Wrap: OpenAI Revenue Concerns Weigh on Wall Street
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.